IL17A and uveitis: Additionally, IL-23-driven autoreactive Th17 cells have been identified as the dominant factor for the disease pathogenesis in autoimmune diseases, including uveitis, multiple sclerosis, arthritis, psoriasis, and inflammatory bowel disease [17], while depletion of IL-17A in Th17 cells do not reduced their pathology in neuroinflammation [18].